Personas / Equipo Humano

Francesc Villarroya Gombau

Buscador de publicaciones

Publicaciones

  • Taxerås SD, Galán M, Campderrós L, Piquer-Garcia I, Pellitero S, Martínez E, Puig R, Lucena I, Tarascó J, Moreno P, Balibrea J, Bel J, Murillo M, Martínez M, Ramon-Krauel M, Puig-Domingo M, Villarroya-Gombau F, Lerin C and Sánchez-Infantes D.

    Differential association between S100A4 levels and insulin resistance in prepubertal children and adult subjects with clinically severe obesity.

    OBESITY SCIENCE & PRACTICE . 6(1): 99-106. Nº de citas: 3

    [doi:10.1002/osp4.381]

  • González-Dávalos L, Álvarez-Pérez M, Quesada T, Cereijo R, Campderrós L, Piña E, Shimada A, Villarroya-Gombau F, Varela-Echavarria A and Mora O.

    Glucocorticoid gene regulation of aquaporin-7.

    Vitamins and Hormones . 112: 179-207. Nº de citas: 2

    [doi:10.1016/bs.vh.2019.08.005]

  • García-Beltran C, Cereijo R, Quesada T, Malpique R, López-Bermejo A, de Zegher F, Ibañez-Toda L and Villarroya-Gombau F.

    Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization

    BMJ OPEN DIABETES RESEARCH & CARE . 8(1): . Nº de citas: 21

    [doi:10.1136/bmjdrc-2019-001035]

  • Cereijo R, Taxerås SD, Piquer-Garcia I, Pellitero S, Martínez E, Tarascó J, Moreno P, Balibrea J, Puig-Domingo M, Jiménez-Pavón D, Lerin C, Villarroya-Gombau F and Sánchez-Infantes D.

    Elevated Levels of Circulating miR-92a Are Associated with Impaired Glucose Homeostasis in Patients with Obesity and Correlate with Metabolic Status After Bariatric Surgery.

    OBESITY SURGERY . 30(1): 174-179. Nº de citas: 17

    [doi:10.1007/s11695-019-04104-y]

  • Jimenez-Pavon D, Corral-Perez J, Sánchez-Infantes D, Villarroya-Gombau F, Ruiz JR and Martinez-Tellez B.

    Infrared Thermography for Estimating Supraclavicular Skin Temperature and BAT Activity in Humans: A Systematic Review.

    Obesity . 27(12): 1932-1949. Nº de citas: 19

    [doi:10.1002/oby.22635]

  • Villarroya-Terrade J, Cereijo R, Gavaldà-Navarro A, Peyrou M, Giralt M and Villarroya-Gombau F.

    New insights into the secretory functions of brown adipose tissue.

    J ENDOCRINOL . 243(2): . Nº de citas: 122

    [doi:10.1530/JOE-19-0295]

  • Quesada T, Gavaldà-Navarro A, Morón S, Campderrós L, Iglesias R, Giralt M and Villarroya-Gombau F.

    GPR120 controls neonatal brown adipose tissue thermogenic induction.

    AM J PHYSIOL-ENDOC M . 317(5): . Nº de citas: 11

    [doi:10.1152/ajpendo.00081.2019]

  • Campderrós L, Moure R, Cairo M, Gavaldà-Navarro A, Quesada T, Cereijo R, Giralt M, Villarroya-Terrade J and Villarroya-Gombau F.

    Brown Adipocytes Secrete GDF15 in Response to Thermogenic Activation.

    Obesity . 27(10): 1606-1616. Nº de citas: 65

    [doi:10.1002/oby.22584]

  • Casasnovas C, Ruiz M, Schlüter A, Naudí A, Fourcade S, Veciana M, Castañer S, Albertí A, Bargalló N, Johnson M, Raymond GV, Fatemi A, Moser AB, Villarroya-Gombau F, Portero-Otín M, Artuch-Iriberri R, Pamplona R and Pujol A.

    Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

    NEUROTHERAPEUTICS . 16(4): 1167-1182. Nº de citas: 34

    [doi:10.1007/s13311-019-00735-2]

  • Zarei M, Pujol E, Quesada T, Villarroya-Gombau F, Barroso E, Vázquez S, Pizarro J, Palomer FX and Vazquez M.

    Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

    BRITISH JOURNAL OF PHARMACOLOGY . 176(13): 2292-2305. Nº de citas: 14

    [doi:10.1111/bph.14678]